Emerging roles for folate receptor FOLR1 in signaling and cancer

By F. Nawaz, E. Kipreos. 2022

Subfields: Biochemistry, Oncology

Citations in the corpus

• Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas (2026, unknown): “Furthermore, FOLR1 is linked to tumor progression and poor prognosis [22].”